Fournier B, Lu C Y, Lagrange P H, Krishnamoorthy R, Philippon A
Laboratoire de Microbiologie, Hôpital Saint-Louis, Université Paris VII, France.
Antimicrob Agents Chemother. 1995 Jun;39(6):1365-8. doi: 10.1128/AAC.39.6.1365.
Klebsiella oxytoca mutants resistant to a variety of beta-lactams were obtained in vitro on aztreonam. Constitutive beta-lactamase production was much higher in the mutants than in the susceptible strains (75-fold). The only difference observed in these mutants compared with the susceptible strains were point mutations in the Pribnow box: a transversion (G-->T) in the first base for one mutant or a transition (G-->A) in the fifth base of the -10 consensus sequence for the other three mutants. The transcriptional output of the beta-lactamase gene (blaOXY) from the mutants was significantly higher than that of the blaOXY gene from the susceptible strains.
在体外通过氨曲南获得了对多种β-内酰胺耐药的产酸克雷伯菌突变体。这些突变体中组成型β-内酰胺酶的产生量比敏感菌株高得多(75倍)。与敏感菌株相比,在这些突变体中观察到的唯一差异是普里布诺框中的点突变:一个突变体在 -10 共有序列的第一个碱基处发生颠换(G→T),另外三个突变体在第五个碱基处发生转换(G→A)。突变体中β-内酰胺酶基因(blaOXY)的转录产量明显高于敏感菌株中blaOXY基因的转录产量。